Citation Impact
Citing Papers
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Hypoxia and chronic lung disease
2007
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
1991
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1990 StandoutNature
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Cell Death
2004 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor
1996 StandoutNobel
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
The biochemistry of apoptosis
2000 StandoutNature
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
1993 Standout
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities
1990
Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
1997 StandoutNatureNobel
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 StandoutNature
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
1988 StandoutNature
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Disseminated Intravascular Coagulation
1999 Standout
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
1993 Standout
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
1994 StandoutNatureNobel
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Mammalian G1 cyclins
1993 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
A novel cyclin encoded by a bcl1-linked candidate oncogene
1991 StandoutNature
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
1984 Standout
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow.
1993 StandoutNobel
Multiple Recurrent Genomic Defects in Follicular Lymphoma
1987
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
1989 StandoutScienceNobel
Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura
1998
There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas
1985
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
The Chromosomal Basis of Human Neoplasia
1983 Science
Amplification and Rearrangement of Hu- ets -1 in Leukemia and Lymphoma with Involvement of 11q23
1986 Science
Amyloid Deposits and Amyloidosis
1980 Standout
Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
1986
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
1991
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
1993 Standout
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
1984 StandoutNatureNobel
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
1985 Science
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Activation of a translocated c-myc gene: role of structural alterations in the upstream region.
1984 StandoutNobel
Comparison of plasma bilirubin turnover and carbon monoxide production in man.
1974
Growth Factors and Cancer
1991 StandoutScience
The clinical spectrum of light chain myeloma
1975
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function
1979
Antioxidant activity of albumin-bound bilirubin.
1987
Metal–Organic Frameworks in Biomedicine
2011 Standout
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes
2007
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Molecular Cloning of the Chromosomal Breakpoint of B-Cell Lymphomas and Leukemias with the t(11;14) Chromosome Translocation
1984 Science
Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
1984 Science
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
2007
Regional expression and cellular localization of the Na(+)-dependent inorganic phosphate cotransporter of rat brain
1995
Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
1985 Standout
Works of Robert B. Howe being referenced
Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption
1997
Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia
1982
Preparation and properties of specifically labeled radiochemically stable 3H-bilirubin.
1970
Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing δ-aminolevulinic acid-4-14C and bilirubin-3H in man
1972
High-Resolution Chromosomes as an Independent Prognostic Indicator in Adult Acute Nonlymphocytic Leukemia
1984
Blood cell abnormalities complicating the hypophosphatemia of hyperalimentation: erythrocyte and platelet ATP deficiency associated with hemolytic anemia and bleeding in hyperalimented dogs.
1974
Interpretation of plasma bilirubin levels based on studies with radioactive bilirubin.
1971
Bilirubin production as a measure of red cell life span.
1972
Studies of bilirubin kinetics in normal adults
1969
Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma
1984
Red Cell Hexosemonophosphate Shunt Deficiency in Uremia
1972
Studies of “Benign” Serum M-Components
1969
The WHO classification of MDS does make a difference
2003
Hypocellular acute leukemia
1982
Constitutional hepatic dysfunction (Gilbert's syndrome)
1970
Abnormal Red Cell Metabolism Causing Hemolysis in Uremia
1973